Surveillance of autopsy cases for D222G substitutions in haemagglutinin of the pandemic (H1N1) 2009 virus in Alberta, Canada

Clinical Microbiology and Infection

Volumn 17, Issue 4, 2011, Pages 582-584

  Drews, S J ^a,b   Pabbaraju, K ^a   Wong, S ^a   Tokaryk, K L ^a   May Hadford, J ^a,c   Lee, B ^d,e   Tellier, R ^a,b   Louie, M ^a,b,d  

^a PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d Provincial Public Health Laboratory   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Autopsy; Influenza; Mutations; Pandemic; Receptors

Indexed keywords

VIRUS HEMAGGLUTININ;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOPSY; CANADA; GENETIC POLYMORPHISM; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; NONHUMAN; PANDEMIC; PRIORITY JOURNAL;

EID: 79952726177     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03341.x     Document Type: Article

References (13)

1. Campbell A, Rodin R, Kropp R et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010; 182: 349-355.
2. Kilander A, Rykkvin R, Dudman SG, Hungnes O. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 2010; 15: 1-3.
3. Mak GC, Au KW, Tai LS et al. Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 2010; 15: 1-2.
4. Glinsky GV. Genomic analysis of pandemic (H1N1) 2009 reveals association of increasing disease severity with emergence of novel hemagglutinin mutations. Cell Cycle 2010; 9: 958-970.
5. Pabbaraju K, Wong S, Wong AA et al. Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus. J Clin Microbiol 2009; 47: 3454-3460.
6. Potdar VA, Chadha MS, Jadhav SM, Mullick J, Cherian SS, Mishra AC. Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS ONE 2010; 5: e9693.
7. Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec 2010;85:21-22.
8. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006; 312: 404-410.
9. Stevens J, Blixt O, Glaser L et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 2006; 355: 1143-1155.
10. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440: 435-436.
11. Tumpey TM, Maines TR, Van HN et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 2007; 315: 655-659.
12. Yang H, Carney P, Stevens J. Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr Influenza 2010;RRN1152.
13. Childs RA, Palma AS, Wharton S et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 2009; 27: 797-799.